Variable |
Survived (N=80) |
None-survived (N=171) |
P |
Average Age ± SD (Range) |
53.4±16.9 (21.82) |
55.7±14.7 (20-91) |
.096a
|
Gender N (%) |
- |
- |
- |
Male |
49 (61.3) |
92(53.8) |
.278b
|
Female |
31 (38.8) |
79(46.2) |
- |
Type of cancer N (%) |
- |
- |
- |
Hematological |
26 (32.5 |
67 (39%) |
.329b
|
Solid |
54 (67.5) |
104 (61%) |
- |
Sepsis N (%) |
- |
- |
- |
Yes |
36 (37.5) |
111 (65%) |
.003b
|
No |
44 (62.5) |
60 (35%) |
- |
APACHE II Score (Mean ± SD) |
19.33±7.51 |
25.43±7.89 |
<.001a
|
APACHE IV Score (Mean ± SD) |
76.50±22.30 |
90.79±22.35 |
<.001a
|
APACHE II Predicted Mortality (Mean ± SD) |
30.5±22.1% |
51.0±23.3% |
<.001a
|
APACHE IV Predicted Mortality (Mean ± SD) |
37.3±21.2% |
59.1±22.9% |
<.001a
|